Emyria has completed a strongly supported placement, to support the scale-up of its MDMA-assisted therapy programs. In this interview, Emyria Managing Director Dr Michael Winlo explains the potential for the company’s new therapy program to treat Post-Traumatic Stress Disorder.Elyria is advancing the MDMA molecule itself and refining its interaction with primary neurotransmitters like serotonin and dopamine.
https://grafa.com/news/asx-video--emyria--asx-emd--to-scale-up-mdma-assisted-therapy-218562
- Forums
- ASX - By Stock
- EMD
- ASX Video: Emyria (ASX:EMD) to scale-up MDMA-assisted therapy
ASX Video: Emyria (ASX:EMD) to scale-up MDMA-assisted therapy
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EMD (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.67M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8979 | 5.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.4¢ | 45000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8979 | 0.052 |
1 | 89097 | 0.049 |
1 | 52083 | 0.048 |
2 | 27020 | 0.046 |
3 | 110000 | 0.045 |
Price($) | Vol. | No. |
---|---|---|
0.054 | 45000 | 1 |
0.055 | 150000 | 1 |
0.058 | 13333 | 1 |
0.060 | 22554 | 1 |
0.062 | 25000 | 1 |
Last trade - 10.45am 03/07/2024 (20 minute delay) ? |
Featured News
EMD (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online